BrightFocus Foundation Appoints New Board Member
(Dec. 22, 2022) Clarksburg, MD—Global brain and vision research nonprofit BrightFocus Foundation has appointed digital health executive, entrepreneur, and speaker Paul A. Campbell as a new member of its board of directors.
“Paul’s work to champion accessibility and improve health across generations through technology is incredible,” said BrightFocus Foundation President and CEO Stacy Pagos Haller. “He exemplifies the type of innovative thinking and commitment to bettering the lives of those afflicted by age-related neurodegenerative diseases that are core to BrightFocus Foundation’s mission.”
Campbell—co-founder and CEO of elovee, Inc., a digital therapy platform designed to treat age-related cognitive impairment—aims to harness the power of technology and innovation to create accessible solutions for underserved populations.
"Contributing to this mission is personal and a privilege. My family is one of the millions around the world impacted by dementia. There is reason for hope—BrightFocus is at the forefront of funding breakthrough science to discover ways to treat, cure, and prevent these diseases of mind and sight,” said Campbell.
Prior to elovee, Campbell was the co-founder and CEO of digital health and wellness mobile app company bLife Inc. and an executive at Microsoft.
About BrightFocus Foundation
BrightFocus Foundation is a premier nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs—Alzheimer’s Disease Research, National Glaucoma Research, and Macular Degeneration Research—the Foundation is currently supporting a $75 million portfolio of 287 scientific projects. BrightFocus has awarded nearly $275 million in groundbreaking medical research funding since inception and shares the latest research findings, expert information, and English/Spanish disease resources to empower the millions impacted by these devastating diseases. Join our community at brightfocus.org.
Don’t miss out.
Receive breakthrough news, research updates, and inspiring stories on the search for a cure in diseases of mind and sight.